# A Study of V132 in Healthy Older Participants (V132-001)

> **NCT07712575** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 280 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** V132 Formulation 1
- **BIOLOGICAL:** V132 Formulation 2
- **BIOLOGICAL:** V132 Formulation 3
- **BIOLOGICAL:** PREVNAR 20™
- **BIOLOGICAL:** CAPVAXIVE™

## Key facts

- **NCT ID:** NCT07712575
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-12
- **Primary completion:** 2028-06-21
- **Final completion:** 2028-06-21
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07712575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07712575, "A Study of V132 in Healthy Older Participants (V132-001)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07712575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*